LI
CNMD icon

LRI Investments’s CONMED CNMD Stock Holding History

LRI Investments’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.12K Hold
248
– – ﹤0.01% 1016
2026
Q1 		$8.77K Buy
248
+24
+11% +$977 ﹤0.01% 921
2025
Q4 		$9.09K Hold
224
– – ﹤0.01% 898
2025
Q3 		$10.5K Hold
224
– – ﹤0.01% 865
2025
Q2 		$11.7K Buy
224
+88
+65% +$4.83K ﹤0.01% 810
2025
Q1 		$8.21K Buy
136
+29
+27% +$1.87K ﹤0.01% 828
2024
Q4 		$7.32K Buy
+107
New +$7.46K ﹤0.01% 837

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

LRI Investments's CNMD Position: Q2 2026 in Review

LRI Investments held its CONMED (CNMD) position steady in Q2 2026 at 248 shares worth $8.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

LRI Investments first reported a position in CNMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.7K in Q2 2025. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • LRI Investments held 248 shares of CONMED worth $8.12K as of Q2 2026.
  • LRI Investments left its CONMED share count unchanged in Q2 2026.
  • CONMED made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1016 holding.
  • LRI Investments first reported a position in CONMED in Q4 2024 and has held it in 7 quarters since.
  • LRI Investments's CONMED position peaked at $11.7K in Q2 2025.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.